CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for AmStem Corporation is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

AmStem Corporation
350 Sansome Street
Suite 680
Phone: (415) 956-2410p:415 956-2410 San Francisco, CA  94140  United States Ticker: SCII SCII

This company is no longer actively traded on any major stock exchange.

Business Summary
AmStem Corporation, formerly Stem Cell Therapy International, Inc., is a development-stage company. The Company is engaged in the licensing of stem cell technology, the sale of stem cell products, and the referral of patients to affiliated stem cell clinics through its wholly-owned subsidiary Stem Cell Therapy International Corp. (Stem Cell Florida). In April 2009, the Company formed AmStem International, Inc., a wholly owned subsidiary of the Company. Its subsidiaries include Stem Cell Therapy International Corp. and AmStem International, Inc. In February 2010, the Company announced that it has completed its merger with Histostem Ltd.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
12/31/20093/31/2009YesYes---

Industries
SIC Code Description
8071 Medical laboratories
8731 Commercial physical and biological research

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chairman of the Board HoonHan 2/9/2010 2/9/2010
Vice President, Chief Scientific Officer DavidStark 51 9/1/2010 1/1/2008
Chief Missions Officer, Director Yong-KilLee 59 4/26/2011 8/18/2010

Business Names
Business Name
AMST
AmStem Corporation
AmStem International, Inc.
4 additional Business Names available in full report.

General Information
Number of Employees: 2 (As of 3/31/2009)
Outstanding Shares: 62,446,080 (As of 2/15/2010)
Shareholders: 289
Stock Exchange: OTC
Federal Tax Id: 880374180
Fax Number: (415) 956-2910
Email Address: info@scticorp.com


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, July 22, 2023